SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-20-000426
Filing Date
2020-07-02
Accepted
2020-07-02 16:58:57
Documents
1
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 15685
  Complete submission text file 0000904454-20-000426.txt   17941
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 0103
Type: 4 | Act: 34 | File No.: 001-39344 | Film No.: 201010483
SIC: 2834 Pharmaceutical Preparations

Mailing Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901
Business Address 410 GEORGE STREET NEW BRUNSWICK NJ 08901 (732) 524-3218
Johnson & Johnson Innovation - JJDC, Inc. (Reporting) CIK: 0000924020 (see all company filings)

State of Incorp.: NJ
Type: 4 | Act: 34 | File No.: 001-39344 | Film No.: 201010484

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)